Synthace: Funding, Investors & Team (Aug 2026)
Synthace is a Life Sciences R&D cloud platform that enables experiments to be rapidly automated, with the resultant data seamlessly integrated. Synthace's goal is to raise universal bioscience productivity, enabling people to better engineer biology for health, food, energy and manufacturing. Central to its technology is Antha, an operating system for biology that enables ease of designing and optimizing biological unit operations that are linked into executable workflows that are reliable, shareable and saleable. Antha spreads biological information in a repeatable way, linking lab equipment, protocols and processes, thereby allowing vast and speedy development, enhancing productivity for any bioscience.
Synthace has raised $35.0M across 1 funding round on record, the most recent a Series C of $35.0M announced in Nov 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Synthace Company Profile and Key Stats
Latest funding round on record: Nov 2021.
Synthace Funding Rounds
Synthace Founders and Leadership Team
No contact details are on record for this team yet.
Synthace Funding Compared to Other Biotechnology Startups
Synthace's latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Synthace in Biotechnology and London
Companies Similar to Synthace
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Synthace Funding FAQs
What does Synthace do?
Synthace is a Life Sciences R&D cloud platform that enables experiments to be rapidly automated, with the resultant data seamlessly integrated. Synthace's goal is to raise universal bioscience productivity, enabling people to better engineer biology for health, food, energy and manufacturing. Central to its technology is Antha, an operating system for biology that enables ease of designing and optimizing biological unit operations that are linked into executable workflows that are reliable, shareable and saleable. Antha spreads biological information in a repeatable way, linking lab equipment, protocols and processes, thereby allowing vast and speedy development, enhancing productivity for any bioscience.
How much funding has Synthace raised?
Synthace has raised $35.0M across 1 round on record. The most recent is a Series C of $35.0M announced in Nov 2021.
When did Synthace last raise funding?
Synthace's most recent funding round on record is a Series C of $35.0M, announced in Nov 2021.
Who is the CEO of Synthace?
Guy Levy-Yurista is listed as CEO at Synthace.
Where is Synthace headquartered?
Synthace is based in London, England, United Kingdom.
How many employees does Synthace have?
Synthace is in the 51-100 employee band.
How does Synthace's funding compare to other Biotechnology startups?
Synthace's latest round of $35.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Synthace Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Synthace is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.